TC BioPharm, a Scottish biotech firm, has won approval to test an experimental T-cell injection therapy to fight COVID-19 by boosting the immune system early in a coronavirus infection, the Financial Times reports. The six-month trial in Edinburgh will involve harvesting T-cells from healthy people, cultivating a large number of the cells in a lab, then injecting the donor cells into hospitalized patients. A large enough infusion could head off the infection before the patient needs to move to intensive care, and even prevent cytokine storms that ravage patients whose body mounts an overly aggressive immune response.
"We have got some evidence that if you kill the virus effectively early on, then [there] should be no reason for the host to have this overwhelming response," Dr. Nik HiraniNik Hirani at Edinburgh University's Center for Inflammation Research tells FT. TC BioPharm founder and CEO Mike Leek said the trial will focus on gamma delta T-cells, the "bully boys" of the immune system. "They circulate in surveillance mode looking for a fight and are in particular attracted to cells that are stressed either by cancer or viral infection, for which they are our first line of defense," he said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
National Enquirer helped Trump in 2016, ex-boss saysSpeed Read David Pecker says the tabloid published fabricated content to hurt Trump's rivals
-
Congress starts clock on TikTok ban in foreign aid billSpeed Read Lawmakers believe that the app poses a national security threat
-
Pros and cons of universal health carePros and Cons A medical system that serves everyone comes with its own costs, and they're not only financial
-
Empty-nest boomers aren't selling their big homesSpeed Read Most Americans 60 and older do not intend to move, according to a recent survey
-
Brazil accuses Musk of 'disinformation campaign'Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
-
Disney board fends off Peltz infiltration bidSpeed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
-
Disney and DeSantis reach detenteSpeed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
-
Visa and Mastercard agree to lower swipe feesSpeed Read The companies will cap the fees they charge businesses when customers use their credit cards
-
Reddit IPO values social media site at $6.4 billionSpeed Read The company makes its public debut on the New York Stock Exchange
-
Housing costs: the root of US economic malaise?speed read Many voters are troubled by the housing affordability crisis
-
Feds cap credit card late fees at $8speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
